Healthcare AI
Using Machine Learning Explainer SHAP to Improve Genomic Data Heatmap Visualisation on a Dashboard
This paper introduces a novel method to enhance genomic data heatmap visualizations on interactive dashboards by integrating SHAP (SHapley Additive exPlanations), an explainable AI (XAI) technique. The approach leverages SHAP to identify and rank the most relevant gene features from high-dimensional genomic datasets, thereby reducing visual clutter and cognitive load. Demonstrated through two case studies involving Rhabdomyosarcoma (RMS) and Acute Lymphoblastic Leukaemia (ALL) datasets, the method enables more targeted and effective visual analytics for domain experts, improving decision-making and trust in ML models.
Why Explainable AI in Genomics Matters for Your Enterprise
The proliferation of large, high-dimensional numerical genomic data presents significant challenges for insightful analysis and visualization. This research addresses the critical need for clearer, more focused representations of complex genetic information, particularly in clinical settings. By integrating SHAP (SHapley Additive exPlanations) within interactive dashboards, we significantly improve the interpretability of gene expression heatmaps, making crucial biological signals more discernible for healthcare professionals.
0%
Time Saved in Feature Identification
0%
Reduction in Misinterpretation Errors
0X
Acceleration of Research Insights
0%
Improved Diagnostic Accuracy Potential
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Overview
Core Technology
Methodology
Key Findings
Application Example
Comparative Analysis
Enhancing Genomic Data Visualization with Explainable AI
The proliferation of large, high-dimensional numerical genomic data presents significant challenges for insightful analysis and visualization. This research addresses the critical need for clearer, more focused representations of complex genetic information, particularly in clinical settings. By integrating SHAP (SHapley Additive exPlanations) within interactive dashboards, we significantly improve the interpretability of gene expression heatmaps, making crucial biological signals more discernible for healthcare professionals.
Key Benefits:
- Reduced cognitive load for analysts and domain experts.
- Improved selection of relevant genomic features for focused analysis.
- Enhanced transparency and trust in machine learning predictions.
- More effective decision-making in genomic data analytics.
- Streamlined visualization of high-dimensional datasets.
SHAP: Unlocking Feature Importance in Genomic Models
SHAP (SHapley Additive exPlanations) is a powerful, model-agnostic explainable artificial intelligence (XAI) method rooted in cooperative game theory. It quantifies the contribution of each feature to a model's prediction, providing deep insights into feature importance. In this context, SHAP is paired with supervised machine learning, specifically Random Forest, to rank genes within high-dimensional numerical genomic datasets, even those with limited labels.
Key Features:
- Model-Agnostic: Works with any machine learning model.
- Feature Contribution: Assigns a Shapley value to each feature, indicating its impact on the prediction.
- Transparency: Enhances understanding of how ML models arrive at their conclusions.
- Dimensionality Reduction: Effectively identifies and prioritizes essential features from vast datasets.
- Robustness: Running SHAP multiple times and aggregating frequencies improves the reliability of feature selection.
Optimized Genomic Visualization Workflow
Our novel method integrates SHAP into an interactive visualization dashboard, providing a structured approach to simplify and focus genomic data analysis. This workflow systematically guides users from raw, complex data to refined, insightful visualizations.
Start with large genomic data (e.g., >200 gene features)
→
Initial interactive dashboard with heatmap, PCA, UMAP
→
Train Random Forest model on genomic data & target labels
→
Apply SHAP to rank all gene features by importance
→
Run SHAP multiple times & aggregate results for robust feature selection
→
Filter dashboard heatmaps to visualize only essential genes
→
Enhance visual analytics outcomes & decision-making
Tangible Improvements in Genomic Data Interpretability
Our experiments across two distinct genomic datasets demonstrated SHAP's efficacy in transforming complex, high-dimensional visualizations into clear, actionable insights. By distilling vast genetic information down to its most impactful features, we significantly enhanced the utility of interactive dashboards for domain experts.
Key Findings:
- Rhabdomyosarcoma (RMS) Case Study: SHAP successfully identified critical gene probes '228170_at' and '226576_at' as most essential for classifying RMS subtypes and predicting patient outcomes. The heatmap visualization, initially cluttered with 258 genes, became focused and interpretable with these key features.
- Acute Lymphoblastic Leukaemia (ALL) Case Study: For ALL, SHAP highlighted 'ITSN2', 'RSF1', and 'KIF20B' as the most frequent and impactful genes related to disease relapse. This allowed for a targeted exploration of gene expressions crucial for understanding patient prognosis.
- Cognitive Load Reduction: The filtered heatmaps, showing only the top-ranked genes, dramatically reduced visual clutter and cognitive load, enabling quicker identification of patterns and relationships between gene expression and clinical profiles.
- Robust Feature Selection: Aggregating SHAP results from multiple Random Forest runs accounted for model randomness, leading to a more reliable and stable identification of truly essential genomic features.
- Enhanced Decision Support: Domain experts can now use these refined visualizations to make more informed decisions by focusing on the genes that demonstrably influence disease outcomes, as explained by the AI.
Case Study: Rhabdomyosarcoma (RMS) Data Analysis
Unveiling Critical Genes for Childhood Cancer Classification
In our first case study, we applied the SHAP-enhanced visualization method to childhood Rhabdomyosarcoma (RMS) data. RMS is a myogenic cancer classified into alveolar (ARMS) and embryonal (ERMS) subtypes, which have distinct molecular and clinical profiles. The dataset included 102 patients and 258 essential gene features, alongside patient information like histology, status (alive/dead), and chromosomal translocation.
Problem: Initially, visualizing all 258 genes on a heatmap made it impossible to discern meaningful patterns due to limited space and high cognitive load.
Solution: We utilized 'Histology' as the target label for a Random Forest model. SHAP was then applied to rank the gene features by their contribution to the model's predictions. By running SHAP multiple times and aggregating the results, we robustly identified the two most critical gene probes: '228170_at' and '226576_at'.
Outcome: The interactive dashboard was then updated to filter the heatmap, displaying only these two essential genes. This focused visualization clearly showed gene expression differences between ARMS and ERMS patients, and their correlation with survival status. For instance, ARMS patients with Pax3 translocation showed a high death rate, while ERMS patients with 'Neg' translocation had a 100% survival rate. This dramatically improved the interpretability of complex genomic data for domain experts, aiding in more targeted decision-making.
| Aspect | Traditional Approach | SHAP-Enhanced Approach |
|---|---|---|
| Feature Selection |
|
|
| Cognitive Load |
|
|
| Interpretability |
|
|
| Decision Support |
|
|
| Scalability |
|
|
Calculate Your Potential ROI with SHAP-Enhanced AI
See how much time and cost your organization could save by adopting explainable AI for complex genomic data analysis. Adjust the parameters to fit your enterprise needs.
Annual Cost Savings
$0
Hours Reclaimed Annually
0
Your Strategic Roadmap to SHAP Integration
Deploying an explainable AI framework for genomic data visualization involves several strategic phases, ensuring seamless integration and maximum impact.
Phase 1: Data Integration & Baseline Visualization
Consolidate diverse genomic datasets into a unified platform. Establish initial interactive dashboards with standard heatmaps, PCA, and UMAP projections. Benchmark current analysis efficiency.
Phase 2: SHAP Model Development & Feature Ranking
Develop and train robust machine learning models (e.g., Random Forest) on relevant genomic datasets. Integrate SHAP explainers to rank feature importance and identify key genomic markers. Establish a multi-run aggregation strategy for SHAP results.
Phase 3: Dashboard Enhancement & User Training
Modify interactive dashboards to dynamically filter and highlight SHAP-ranked features on heatmaps. Conduct training sessions for bioinformaticians and clinicians on utilizing the SHAP-enhanced visualizations for targeted analysis and decision-making.
Phase 4: Validation, Iteration & Scalability
Validate the effectiveness of the SHAP-enhanced system with real-world clinical data and expert feedback. Continuously refine models and visualization techniques based on user insights. Plan for scalability to accommodate future data volumes and research questions.
Ready to Transform Your Genomic Analysis?
Connect with our AI specialists to explore how SHAP-enhanced visualizations can revolutionize your research and diagnostic capabilities.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat